Joseph Beaulieu
No más puestos en curso
Historial de carrera de Joseph Beaulieu
Antiguos cargos conocidos de Joseph Beaulieu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EPIZYME, INC. | Comptroller/Controller/Auditor | 01/07/2018 | 01/02/2023 |
| Treasurer | 01/07/2018 | - | |
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 01/05/2009 | 31/08/2011 |
| Director de Investigación - Acciones | 01/05/2009 | 31/08/2011 | |
| ABN AMRO Securities (USA), Inc. | Analyst-Equity | 31/10/1999 | 31/10/1999 |
Formación de Joseph Beaulieu.
| The University of Chicago | Undergraduate Degree |
| University of Illinois | Graduate Degree |
| Wallace E Carroll School of Management | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Analyst-Equity | 2 |
| Undergraduate Degree | 2 |
| Director of Research - Equity | 1 |
Sectorial
| Consumer Services | 4 |
| Finance | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
| ABN AMRO Securities (USA), Inc. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Beaulieu
- Experiencia